Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Yost

Showing results (71-80 of 140) with videos related to

Pageof 14
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|June 5, 2021
Identification of a T-bet<sup>hi</sup> Quiescent Exhausted CD8 T Cell Subpopulation That Can Differentiate into TIM3<sup>+</sup>CX3CR1<sup>+</sup> Effectors and Memory-like CellsSaravanan Raju, Yu Xia, Bence Daniel, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|January 5, 2002
Clinical benefits and tolerability of increased fill volumes in Japanese peritoneal dialysis patientsA Fukatsu, Y Komatsu, H Senoh, et al.
Nucleic Acids Research|April 12, 2012
Identification of high-confidence somatic mutations in whole genome sequence of formalin-fixed breast cancer specimensShawn E Yost, Erin N Smith, Richard B Schwab, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 16, 2019
Comprehensive Profiling of Poor-Risk Paired Primary and Recurrent Triple-Negative Breast Cancers Reveals Immune Phenotype ShiftsKatherine E Hutchinson, Susan E Yost, Ching-Wei Chang, et al.
Plos One|March 10, 2020
Multi-panel immunofluorescence analysis of tumor infiltrating lymphocytes in triple negative breast cancer: Evolution of tumor immune profiles and patient prognosisTing-Fang He, Susan E Yost, Paul H Frankel, et al.
Scientific Reports|March 16, 2019
Rapid and reversible suppression of ALT by DAXX in osteosarcoma cellsKathryn E Yost, Sarah F Clatterbuck Soper, Robert L Walker, et al.
BMC Cancer|January 23, 2019
CCNE1 amplification is associated with poor prognosis in patients with triple negative breast cancerZi-Ming Zhao, Susan E Yost, Katherine E Hutchinson, et al.
Cells|September 5, 2019
Eribulin Synergistically Increases Anti-Tumor Activity of an mTOR Inhibitor by Inhibiting pAKT/pS6K/pS6 in Triple Negative Breast CancerWei Wen, Emily Marcinkowski, David Luyimbazi, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 26, 2022
Polycomb-mediated genome architecture enables long-range spreading of H3K27 methylationKaterina Kraft, Kathryn E Yost, Sedona E Murphy, et al.
Cancers|July 9, 2022
Genomic Markers of CDK 4/6 Inhibitor Resistance in Hormone Receptor Positive Metastatic Breast CancerJin Sun Lee, Susan E Yost, Sierra Min Li, et al.
Pageof 14

Showing results (71-80 of 140) with videos related to

Sort By:
Pageof 14
Journal of Immunology (Baltimore, Md. : 1950)|June 5, 2021
Identification of a T-bet<sup>hi</sup> Quiescent Exhausted CD8 T Cell Subpopulation That Can Differentiate into TIM3<sup>+</sup>CX3CR1<sup>+</sup> Effectors and Memory-like CellsSaravanan Raju, Yu Xia, Bence Daniel, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|January 5, 2002
Clinical benefits and tolerability of increased fill volumes in Japanese peritoneal dialysis patientsA Fukatsu, Y Komatsu, H Senoh, et al.
Nucleic Acids Research|April 12, 2012
Identification of high-confidence somatic mutations in whole genome sequence of formalin-fixed breast cancer specimensShawn E Yost, Erin N Smith, Richard B Schwab, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 16, 2019
Comprehensive Profiling of Poor-Risk Paired Primary and Recurrent Triple-Negative Breast Cancers Reveals Immune Phenotype ShiftsKatherine E Hutchinson, Susan E Yost, Ching-Wei Chang, et al.
Plos One|March 10, 2020
Multi-panel immunofluorescence analysis of tumor infiltrating lymphocytes in triple negative breast cancer: Evolution of tumor immune profiles and patient prognosisTing-Fang He, Susan E Yost, Paul H Frankel, et al.
Scientific Reports|March 16, 2019
Rapid and reversible suppression of ALT by DAXX in osteosarcoma cellsKathryn E Yost, Sarah F Clatterbuck Soper, Robert L Walker, et al.
BMC Cancer|January 23, 2019
CCNE1 amplification is associated with poor prognosis in patients with triple negative breast cancerZi-Ming Zhao, Susan E Yost, Katherine E Hutchinson, et al.
Cells|September 5, 2019
Eribulin Synergistically Increases Anti-Tumor Activity of an mTOR Inhibitor by Inhibiting pAKT/pS6K/pS6 in Triple Negative Breast CancerWei Wen, Emily Marcinkowski, David Luyimbazi, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 26, 2022
Polycomb-mediated genome architecture enables long-range spreading of H3K27 methylationKaterina Kraft, Kathryn E Yost, Sedona E Murphy, et al.
Cancers|July 9, 2022
Genomic Markers of CDK 4/6 Inhibitor Resistance in Hormone Receptor Positive Metastatic Breast CancerJin Sun Lee, Susan E Yost, Sierra Min Li, et al.
Pageof 14